Difference between revisions of "Template:Glutamate receptor modulators"

From blackwiki
Jump to navigation Jump to search
imported>Medgirl131
(Replaced content with '{{Navboxes | title = Glutamate receptor modulators | titlestyle = background:#ccccff | state = {{{state<includeonly>|collapsed<...')
 
(136 intermediate revisions by 30 users not shown)
Line 1: Line 1:
{{Navbox
+
{{Navboxes
| name = Glutamatergics
+
  | title = [[Glutamate receptor]] [[receptor modulator|modulator]]s
| title = [[Glutamate]]rgics
+
  | titlestyle = background:#ccccff
| groupstyle = background: LightYellow
+
  | state = {{{state<includeonly>|collapsed</includeonly>}}}
| state = collapsed
+
| list1 =  
 
+
{{Ionotropic glutamate receptor modulators}}
  | group1 = [[Ionotropic]]
+
{{Metabotropic glutamate receptor modulators}}
  | list1  = {{Navbox subgroup
+
}}<noinclude>
  | groupstyle = background: LightYellow
+
{{collapsible option}}
 
+
[[Category:Drug templates by receptor, channel, or pump]]
    | group1 = [[AMPA receptor|AMPA]]
 
    | list1  = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]&nbsp;•  [[AMPA]]&nbsp;•  [[Domoic acid]]&nbsp;•  [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]]&nbsp;•  [[Cyclothiazide]]&nbsp;•  [[CX-516]]&nbsp;•  [[CX-546]]&nbsp;•  [[CX-614]]&nbsp;•  [[CX-691]]&nbsp;•  [[CX-717]]&nbsp;•  [[Diazoxide]]&nbsp;•  [[Hydrochlorothiazide|HCTZ]]&nbsp;•  [[IDRA-21]]&nbsp;•  [[LY-392,098]]&nbsp;•  [[LY-404,187]]&nbsp;•  [[LY-451,395]]&nbsp;•  [[LY-451,646]]&nbsp;•  [[LY-503,430]]&nbsp;•  [[Oxiracetam]]&nbsp;•  [[PEPA (drug)|PEPA]]&nbsp;•  [[Piracetam]]&nbsp;•  [[Pramiracetam]]&nbsp;•  [[S-18986]]&nbsp;•  [[Sunifiram]]&nbsp;•  [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]]&nbsp;•  [[Barbiturates]]&nbsp;•  [[Caroverine]]&nbsp;•  [[CNQX]]&nbsp;•  [[DNQX]]&nbsp;•  [[GYKI-52466]]&nbsp;•  [[NBQX]]&nbsp;•  [[Perampanel]]&nbsp;•  [[Talampanel]]&nbsp;•  [[Tezampanel]]&nbsp;•  [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]]
 
 
 
    | group2 = [[NMDA receptor|NMDA]]
 
    | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]&nbsp;•  [[Glutamate]]&nbsp;•  [[Homoquinolinic acid]]&nbsp;•  [[Ibotenic acid]]&nbsp;•  [[NMDA]]&nbsp;•  [[Quinolinic acid]]&nbsp;•  [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]&nbsp;•  [[ACPC]]&nbsp;•  [[ACPD]]&nbsp;•  [[Alanine]]&nbsp;•  [[Carboxycyclopropylglycine|CCG]]&nbsp;•  [[Cycloserine]]&nbsp;•  [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]&nbsp;•  [[Fluoroalanine]]&nbsp;•  [[Glycine]]&nbsp;•  [[HA-966]]&nbsp;•  [[L-687,414]]&nbsp;•  [[Milacemide]]&nbsp;•  [[Sarcosine]]&nbsp;•  [[Serine]]&nbsp;•  [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]&nbsp;•  [[Spermidine]]&nbsp;•  [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]&nbsp;•  [[AP-7 (drug)|AP7]]&nbsp;•  [[CGP-37849]]&nbsp;•  [[CGP-39551]]&nbsp;•  [[CGP-39653]]&nbsp;•  [[CGP-40116]]&nbsp;•  [[CGS-19755]]&nbsp;•  [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]&nbsp;•  [[LY-233,053]]&nbsp;•  [[LY-235,959]]&nbsp;•  [[LY-274,614]]&nbsp;•  [[MDL-100,453]]&nbsp;•  [[Midafotel|Midafotel (d-CPPene)]]&nbsp;•  [[NPC-12,626]]&nbsp;•  [[NPC-17,742]]&nbsp;•  [[PBPD]]&nbsp;•  [[PEAQX]]&nbsp;•  [[Perzinfotel]]&nbsp;•  [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]&nbsp;•  [[SDZ-220581]]&nbsp;•  [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]&nbsp;•  [[Caroverine]]&nbsp;•  [[Dexanabinol]]&nbsp;•  [[FPL-12495]]&nbsp;•  [[FR-115,427]]&nbsp;•  [[Hodgkinsine]]&nbsp;•  [[Magnesium]]&nbsp;•  [[MDL-27,266]]&nbsp;•  [[NPS-1506]]&nbsp;•  [[Psychotridine]]&nbsp;•  [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]&nbsp;•  [[3-MeO-PCP]]&nbsp;•  [[8a-Phenyldecahydroquinoline|8A-PDHQ]]&nbsp;•  [[Amantadine]]&nbsp;•  [[Aptiganel]]&nbsp;•  [[ARL-12,495]]&nbsp;•  [[ARL-15,896-AR]]&nbsp;•  [[ARL-16,247]]&nbsp;•  [[Budipine]]&nbsp;•  [[Delucemine]]&nbsp;•  [[Dexoxadrol]]&nbsp;•  [[Dextrallorphan]]&nbsp;•  [[Dieticyclidine]]&nbsp;•  [[Dizocilpine]]&nbsp;•  [[Endopsychosin]]&nbsp;•  [[Esketamine]]&nbsp;•  [[Etoxadrol]]&nbsp;•  [[Eticyclidine]]&nbsp;•  [[Gacyclidine]]&nbsp;•  [[Ibogaine]]&nbsp;•  [[Indantadol]]&nbsp;•  [[Ketamine]]&nbsp;•  [[Ketobemidone]]&nbsp;•  [[Loperamide]]&nbsp;•  [[Memantine]]&nbsp;•  [[Meperidine|Meperidine (Pethidine)]]&nbsp;•  [[Methadone]]&nbsp;•  [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]])&nbsp;•  [[Methoxetamine]]&nbsp;•  [[Milnacipran]]&nbsp;•  [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]])&nbsp;•  [[NEFA (drug)|NEFA]]&nbsp;•  [[Neramexane]]&nbsp;•  [[Nitrous oxide]]&nbsp;•  [[Noribogaine]]&nbsp;•  [[Orphenadrine]]&nbsp;•  [[PCPr]]&nbsp;•  [[Phencyclamine]]&nbsp;•  [[Phencyclidine]]&nbsp;•  [[Propoxyphene]]&nbsp;•  [[Remacemide]]&nbsp;•  [[Rhynchophylline]]&nbsp;•  [[Riluzole]]&nbsp;•  [[Rimantadine]]&nbsp;•  [[Rolicyclidine]]&nbsp;•  [[Sabeluzole]]&nbsp;•  [[Tenocyclidine]]&nbsp;•  [[Tiletamine]]&nbsp;•  [[Tramadol]]&nbsp;•  [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]&nbsp;•  [[ACEA-1328]]&nbsp;•  [[1-Aminocyclopropanecarboxylic acid|ACPC]]&nbsp;•  [[Carisoprodol]]&nbsp;•  [[CGP-39653]]&nbsp;•  [[7-Chlorokynurenate|CKA]]&nbsp;•  [[DCKA]]&nbsp;•  [[Felbamate]]&nbsp;•  [[Gavestinel]]&nbsp;•  [[GV-196,771]]&nbsp;•  [[Kynurenic acid]]&nbsp;•  [[L-689,560]]&nbsp;•  [[L-701,324]]&nbsp;•  [[Lacosamide]]&nbsp;•  [[Licostinel]]&nbsp;•  [[LU-73,068]]&nbsp;•  [[MDL-105,519]]&nbsp;•  [[Meprobamate]]&nbsp;•  [[MRZ 2/576]]&nbsp;•  [[PNQX]]&nbsp;•  [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]&nbsp;•  [[CO-101,244|CO-101,244 (PD-174,494)]]&nbsp;•  [[CP-101,606]]&nbsp;•  [[Eliprodil]]&nbsp;•  [[Haloperidol]]&nbsp;•  [[Ifenprodil]]&nbsp;•  [[Isoxsuprine]]&nbsp;•  [[Nylidrin]]&nbsp;•  [[Ro8-4304]]&nbsp;•  [[Ro25-6981]]&nbsp;•  [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]&nbsp;•  [[Co 101676]]&nbsp;•  [[1,3-Diaminopropane|Diaminopropane]]&nbsp;• [[Acamprosate]]&nbsp;• [[Diethylenetriamine]]&nbsp;•  [[Huperzine A]]&nbsp;•  [[Putrescine]]&nbsp;•  [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]&nbsp;•  [[Diethyl ether]]&nbsp;•  [[Enflurane]]&nbsp;•  [[Ethanol|Ethanol (Alcohol)]]&nbsp;•  [[Halothane]]&nbsp;•  [[Isoflurane]]&nbsp;•  [[Methoxyflurane]]&nbsp;•  [[Toluene]]&nbsp;•  [[1,1,1-Trichloroethane|Trichloroethane]]&nbsp;•  [[2,2,2-Trichloroethanol|Trichloroethanol]]&nbsp;•  [[Trichloroethylene]]&nbsp;•  [[Xylene]]
 
 
 
    | group3 = [[Kainate receptor|Kainate]]
 
    | list3  = '''Agonists:''' [[5-Iodowillardiine]]&nbsp;•  [[ATPA]]&nbsp;•  [[Domoic acid]]&nbsp;•  [[Kainic acid]]&nbsp;•  [[LY-339,434]]&nbsp;•  [[SYM-2081]]<br/>'''Antagonists:''' [[CNQX]]&nbsp;•  [[DNQX]]&nbsp;•  [[LY-382,884]]&nbsp;•  [[NBQX]]&nbsp;•  [[NS102]]&nbsp;•  [[Tezampanel]]&nbsp;•  [[Topiramate]]&nbsp;•  [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]]
 
 
 
    }}
 
 
 
  | group2 = [[Metabotropic glutamate receptor|Metabotropic]]
 
  | list2 = {{Navbox subgroup
 
  | groupstyle = background: LightYellow
 
 
 
    | group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]]
 
    | list1 = '''Agonists:''' ''Unselective:'' [[ACPD]]&nbsp;•  [[Dihydroxyphenylglycine|DHPG]]&nbsp;•  [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]]&nbsp;•  [[Ro67-4853]]&nbsp;•  [[Ro67-7476]]&nbsp;•  [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]]&nbsp;•  [[CDPPB]]&nbsp;•  [[CHPG]]&nbsp;•  [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]]&nbsp;•  [[VU-1545]]<br/>'''Antagonists:''' ''Unselective:'' [[MCPG]]&nbsp;•  [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]]&nbsp;•  [[CPCCOEt]]&nbsp;•  [[LY-367,385]]&nbsp;•  [[LY-456,236]]; ''mGlu5-selective:'' [[DMeOB]]&nbsp;•  [[Fenobam]]&nbsp;•  [[LY-344,545]]&nbsp;•  [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]&nbsp;•  [[MTEP]]&nbsp;•  [[SIB-1757]]&nbsp;•  [[SIB-1893]]
 
 
 
    | group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]]
 
    | list2  = '''Agonists:''' ''Unselective:'' [[CBiPES]]&nbsp;•  [[DCG-IV]]&nbsp;•  [[Eglumegad]]&nbsp;•  [[LY-379,268]]&nbsp;•  [[LY-404,039]]&nbsp;•  [[LY-487,379]]&nbsp;•  [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]]&nbsp;•  [[LY-566,332]]<br/>'''Antagonists:''' ''Unselective:'' [[APICA (drug)|APICA]]&nbsp;•  [[EGLU]]&nbsp;•  [[HYDIA]]&nbsp;•  [[LY-307,452]]&nbsp;•  [[LY-341,495]]&nbsp;•  [[MCPG]]&nbsp;•  [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]]
 
 
 
    | group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]]
 
    | list3  = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]&nbsp;•  [[VU-001,171]]&nbsp;•  [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]]<br/>'''Antagonists:''' ''Unselective:'' [[CPPG]]&nbsp;•  [[MAP4 (drug)|MAP4]]&nbsp;•  [[MSOP (drug)|MSOP]]&nbsp;•  [[MPPG]]&nbsp;•  [[MTPG]]&nbsp;•  [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]]
 
 
 
    }}
 
 
 
  | group3 = [[Glutamate transporter|Transporter]]<br />[[Reuptake inhibitor|inhibitor]]s
 
  |  list3 = {{Navbox subgroup
 
  | groupstyle = background: LightYellow
 
 
 
    | group1 = [[Glutamate transporter|EAAT]]s
 
    |  list1 = [[Dihydrokainic acid|DHKA]]&nbsp;•  [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]]&nbsp;•  [[WAY-213,613]]
 
 
 
    | group2 = [[Vesicular glutamate transporters|vGluTs]]
 
    |  list2 = [[7-Chlorokynurenic acid|7-CKA]]&nbsp;•  [[Evans blue]]
 
 
 
  }}
 
 
 
}}
 
<noinclude>
 
[[Category:Drug templates by receptor, channel, or pump|{{PAGENAME}}]]
 
 
</noinclude>
 
</noinclude>

Latest revision as of 10:57, 27 August 2017

Template:Navboxes Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Glutamate receptor modulators|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Glutamate receptor modulators|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Glutamate receptor modulators|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.